Skip to main content

Peer Review reports

From: Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells

Original Submission
8 Feb 2021 Submitted Original manuscript
18 Feb 2021 Author responded Author comments - Mingyi Li
19 Feb 2021 Author responded Author comments - Mingyi Li
Resubmission - Version 2
18 Feb 2021 Submitted Manuscript version 2
4 Mar 2021 Reviewed Reviewer Report
23 Mar 2021 Reviewed Reviewer Report - Arun Jajoriya
17 Apr 2021 Author responded Author comments - Mingyi Li
Resubmission - Version 3
17 Apr 2021 Submitted Manuscript version 3
23 Apr 2021 Author responded Author comments - Mingyi Li
Resubmission - Version 4
23 Apr 2021 Submitted Manuscript version 4
11 May 2021 Reviewed Reviewer Report - Arun Jajoriya
13 Jun 2021 Author responded Author comments - Mingyi Li
Resubmission - Version 5
13 Jun 2021 Submitted Manuscript version 5
Publishing
15 Jun 2021 Editorially accepted
6 Jul 2021 Article published 10.1186/s12906-021-03356-5

You can find further information about peer review here.

Back to article page